Why the study?
Readmission after treatment for ischemic cerebrovascular disease is a burden on patients and families, motivating an investigation into readmission causes and characteristics.
Recurrence of cerebral infarction remains a significant cause of 90-day readmission after ischemic stroke, emphasizing the importance of secondary prevention in the community.
Supports emphasis on secondary prevention after ischemic stroke; leaves open whether targeted interventions reduce 90-day readmissions.
【背景および目的】虚血性脳血管障害治療後の再入院は,患者,家族の負担となる.当院症例の再入院原因と特徴を検討した.【方法】2018年1月~2022年12月に当院で急性期治療を行った1,875例中,死亡43例を除く1,832例を対象に,退院後90日以内の再入院を後ろ向きに調査し,13年前と比較した.【結果】再入院は195例(10.6%)で,虚血性脳血管障害再発47例(24.1%),予定外再入院79例(40.5%),予定再入院69例(35.4%)で,各再入院率は2.6%,4.3%,3.8%だった.再発時transient ischemic attack(TIA)を除く42例中32例(76.2%)が同一病型で再発し,40例(85.1%)が60日以内だった.予定外,予定再入院の最多理由は感染症,心房細動アブレーションだった.再入院率と脳梗塞再発による再入院率は前回調査と同等だった.【結論】脳梗塞再発は重要な再入院要因であり,地域での二次予防が必要である.
No takes yet. Share an insight, caveat, or question.
瑠美 et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: